FDA approved Pentacel, a new combination DTaP-IPV-Hib vaccine for use in children 6 wksﾖ4 yrs of age
On Jun. 20, 2008, the FDA approved Pentacel (Sanofi Pasteur), a new combination DTaP-IPV-Hib vaccine for use in children 6 wksﾖ4 yrs of age.
Tags:
Source: U.S. Centers for Disease Control and Prevention
Credit:
